Oxadiazolylindazole Sodium Channel Modulators are Neuroprotective toward Hippocampal Neurones

被引:58
作者
Clutterbuck, Lisa A. [1 ]
Posada, Cristina Garcia [1 ]
Visintin, Cristina [1 ]
Riddall, Dieter R. [1 ]
Lancaster, Barrie [1 ]
Gane, Paul J. [1 ]
Garthwaite, John [1 ]
Selwood, David L. [1 ]
机构
[1] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England
基金
英国惠康基金;
关键词
MULTIPLE-SCLEROSIS; NEUROPATHIC PAIN; NA+ CHANNELS; RAT-BRAIN; DEPENDENT INHIBITION; SPINAL-CORD; MECHANISMS; BLOCKERS; 1,2,4-OXADIAZOLES; LAMOTRIGINE;
D O I
10.1021/jm801180p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the discovery of a new class of neuroprotective voltage-dependent sodium channel modulators exemplified by (5-(1-benzyl-1H-indazol-3-yl)-1,2,4-oxadiazol-3-yl)methanamine. 11 (CFM1178). The compounds were inhibitors of [C-14]guanidinium ion flux in rat forebrain synaptosomes and displaced binding of the sodium channel ligand [H-3]BW202W92. 11 and the corresponding N-2-benzyl isomer, 38 (CFM6058), demonstrated neuroprotective activity in hippocampal slices comparable to sipatrigine. CYP450 enzyme inhibition observed with 11 was reduced with 38. In electrophysiological experiments on dissociated hippocampal neurons, these two compounds caused use- and voltage-dependent block of sodium currents. Sodium channel isoform profiling against Na(v)1.1-1.8 demonstrated that the standard sodium channel blocker lamotrigine had modest activity against Na(v)1.1, while sipatrigine was generally more potent and less selective. 11 and 38 showed potent activity against Na(v)1.6, pointing to pharmacological block of this isoform being consistent with the neuroprotective effect. 38 also showed use dependent block of Na(v)1.6 in HEK cells.
引用
收藏
页码:2694 / 2707
页数:14
相关论文
共 60 条
[1]   Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024 [J].
Ambrósio, AF ;
Soares-da-Silva, P ;
Carvalho, CM ;
Carvalho, AP .
NEUROCHEMICAL RESEARCH, 2002, 27 (1-2) :121-130
[2]   The role of sodium channels in chronic inflammatory and neuropathic pain [J].
Amir, Ron ;
Argoff, Charles E. ;
Bennett, Gary J. ;
Cummins, Theodore R. .
JOURNAL OF PAIN, 2006, 7 (05) :S1-S29
[3]   Medicinal chemistry of neuronal voltage-gated sodium channel blockers [J].
Anger, T ;
Madge, DJ ;
Mulla, M ;
Riddall, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (02) :115-137
[4]   Anticonvulsants for the treatment of neuropathic pain syndromes [J].
Miroslav Backonja .
Current Pain and Headache Reports, 2003, 7 (1) :39-42
[5]   Involvement of Na+ channels in pain pathways [J].
Baker, MD ;
Wood, JN .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (01) :27-31
[6]  
Benet L., 1996, The pharmacological basis of therapeutics, V9th, P3
[7]  
Bensimon Gilbert, 2004, Expert Opin Drug Saf, V3, P525, DOI 10.1517/14740338.3.6.525
[8]   Early treatment suppresses the development of spike-wave epilepsy in a rat model [J].
Blumenfeld, Hal ;
Klein, Joshua P. ;
Schridde, Ulrich ;
Vestal, Matthew ;
Rice, Timothy ;
Khera, Davender S. ;
Bashyal, Chhitij ;
Giblin, Kathryn ;
Paul-Laughinghouse, Crystal ;
Wang, Frederick ;
Phadke, Anuradha ;
Mission, John ;
Agarwal, Ravi K. ;
Englot, Dario J. ;
Motelow, Joshua ;
Nersesyan, Hrachya ;
Waxman, Stephen G. ;
Levin, April R. .
EPILEPSIA, 2008, 49 (03) :400-409
[9]   From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels [J].
Catterall, WA .
NEURON, 2000, 26 (01) :13-25
[10]   STRUCTURE AND FUNCTION OF VOLTAGE-GATED ION CHANNELS [J].
CATTERALL, WA .
ANNUAL REVIEW OF BIOCHEMISTRY, 1995, 64 :493-531